Omada Health shares surge 6.83% as anticipation builds for J.P. Morgan Healthcare Conference presentation

Omada Health shares surged 6.8276% in pre-market trading on Dec. 23, 2025, driven by anticipation of its upcoming presentation at a major industry event. The stock’s pre-market rally suggests investor optimism ahead of the company’s participation in the 44th Annual J.P. Morgan Healthcare Conference.

The company announced that senior management will present at the conference on Jan. 14, 2026, at 9 a.m. PST. The session, hosted in San Francisco, will feature insights into Omada’s virtual healthcare platform, which focuses on managing cardiometabolic and musculoskeletal conditions through AI-driven personalized care. A live webcast and replay will be available via the company’s investor relations page.

Omada Health’s business model centers on delivering scalable, evidence-based solutions for chronic disease management, including support for patients using GLP-1s and anti-obesity medications. With over a decade of clinical data and 30 peer-reviewed publications, the company has served more than one million members across 2,000 clients, including Fortune 500 employers and health systems. Its Compassionate Intelligence approach combines human care teams with connected devices and AI technology to address rising demand for remote healthcare services.

The pre-market reaction underscores market confidence in Omada’s ability to showcase its value proposition at the conference, particularly amid growing interest in digital health solutions. The event provides a key platform to reinforce the company’s position in a competitive landscape targeting chronic disease management and cost-effective care delivery.